Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3566668

Documents

Beta release

Statistics of Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
Statistics for this year
PeriodVisitsDownloads
20243123
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0511
2024-0622
2024-0700